Vita Life Sciences Limited (ASX:VLS)
Australia · Delayed Price · Currency is AUD 2.460
-0.070 (-2.77%)
May 7, 2026, 4:10 PM AEST
Vita Life Sciences Earnings Call Transcripts
Fiscal Year 2025
-
Record revenue and profit growth were reported, with strong cash reserves and an increased dividend. Strategic expansion in Asia, especially Vietnam, China, and Indonesia, remains a focus, while all AGM resolutions passed with strong support.